Skip to main content
SearchLogin or Signup

Review 1: "Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states"

This preprint reports a high detection rate of SARS-CoV-2 using wastewater surveillance and finds that virus detection precedes clinical indicators. Reviewers deem these findings potentially informative, recommending large scale studies to confirm findings.

Published onJun 16, 2021
Review 1: "Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states"
1 of 2
key-enterThis Pub is a Review of
Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states

AbstractWastewater-based disease surveillance is a promising approach for monitoring community outbreaks. Here we describe a nationwide campaign to monitor SARS-CoV-2 in the wastewater of 159 counties in 40 U.S. states, covering 13% of the U.S. population from February 18 to June 2, 2020. Out of 1,751 total samples analyzed, 846 samples were positive for SARS-CoV-2 RNA, with overall viral concentrations declining from April to May. Wastewater viral titers were consistent with, and appeared to precede, clinical COVID-19 surveillance indicators, including daily new cases. Wastewater surveillance had a high detection rate (>80%) of SARS-CoV-2 when the daily incidence exceeded 13 per 100,000 people. Detection rates were positively associated with wastewater treatment plant catchment size. To our knowledge, this work represents the largest-scale wastewater-based SARS-CoV-2 monitoring campaign to date, encompassing a wide diversity of wastewater treatment facilities and geographic locations. Our findings demonstrate that a national wastewater-based approach to disease surveillance may be feasible and effective.

RR:C19 Evidence Scale rating by reviewer:

  • Potentially informative. The main claims made are not strongly justified by the methods and data, but may yield some insight. The results and conclusions of the study may resemble those from the hypothetical ideal study, but there is substantial room for doubt. Decision-makers should consider this evidence only with a thorough understanding of its weaknesses, alongside other evidence and theory. Decision-makers should not consider this actionable, unless the weaknesses are clearly understood and there is other theory and evidence to further support it.



This manuscript, although containing a big amount of data, fails to clearly prove the claims included, mainly due to flaws in the methodological process.

The volume of wastewater sampled is too small to ensure the detection of genome copies of SARS-CoV-2 in samples with low levels of viruses. Two different water concentration methods are applied, which use 40 ml and 15 ml of wastewater, respectively. These volumes will permit genome detection only in highly contaminated samples, which may explain why only 49% of the samples were detected to be positive for SARS-CoV-2 during the first wave of the pandemic. Additionally, the description provided does not precisely reflect the volume of the water concentrate used for RNA extraction or the volume of RNA used for the RT-qPCR. The limit of quantification is also missing.

Another critical issue is the lack of a process control coronavirus for the estimation of the efficiency of the concentration procedure, which is required for the detection of SARS-CoV-2 concentration failures.

Additionally, there is no information on the confirmation method used. It would be advisable to use at least two RTqPCR targets, preferably from different genomic regions. In the methods sections, it is described that samples were analyzed for the CDC N1 or N2 targets. Fig 1, Fig S1 and Fig S2 legends do not contain information on the target used for the SARS-CoV-2 quantification. For instance, it is not clear if all data points included in the figures were quantified using the same target. Also, it is not described if all points were confirmed with a second target.

Several claims on correlations between viral loads in wastewater samples and cases in the population are given, but no methods on the statistical analysis employed are provided. Additionally, assessments looking for the relationship of SARS-CoV-2 genome copy numbers in wastewater samples and cases in the population were performed using clinical data reported for the day on which the samples were obtained. However, SARS-CoV-2 infected patients shed viruses in feces for a period extending up to 7 to 21 days post-infection. Accordingly, the conclusions presented may not be accurate.

While figures are generally well presented, results in the text are sometimes confusing.     

Literature is not extensive and, while many references are missing, some references that have been cited as preprints have already been published.

The flaws in the methods are significant, bringing doubts on the accuracy of the claims and conclusions.


No comments here